Sanofi Labels Biosimilars 'Enormous Distraction'

French Player Has A Small Biosimilar Presence

 
• By Dean Rudge
  
Insulin pen
Sanofi exited diabetes research last year but kept hold of a biosimilar insulin aspart candidate • Source: Shutterstock

More from Biosimilars

More from Products